Centor Score Calculator
Score the four original adult Centor findings, display the age-adjusted McIsaac total separately, and place both in the 2025 IDSA testing-risk framework without recommending antibiotics from symptoms alone.
Mark findings from a clinical evaluation
Original Centor and modified McIsaac scoring
Add one point each for temperature above 38°C (100.4°F), absence of cough, swollen tender anterior cervical nodes, and tonsillar exudate or swelling. That produces the original Centor score from 0 to 4.
For the McIsaac modification, add 1 for age 3–14, add 0 for age 15–44, and subtract 1 for age 45 or older. The four clinical findings remain the same. This calculator shows both totals so the age change is never hidden.
The 2025 IDSA update says scoring systems are most helpful for identifying people with a low probability of GAS in whom testing is unlikely to help. It does not endorse using a high clinical score as a laboratory result.
Worked age-16 score of 4
The default profile has fever above 38°C, no cough, tender swollen anterior cervical nodes, and tonsillar exudate or swelling. Each contributes 1, so the original Centor score is 4.
Age 16 falls in the McIsaac 15–44 bracket and contributes zero. The McIsaac total remains 4. The 2025 IDSA table associates original Centor 4 with approximately 57% positive GAS testing and the McIsaac 4–5 high band with 50.7%–69.3%.
Even in that high band, many people will not have a positive GAS test. A test and clinical evaluation can prevent both missed alternative diagnoses and unnecessary antibiotic exposure. Percentages come from validation populations and vary with prevalence and setting.
Risk bands in the 2025 IDSA table
Low
Centor 0–1: 7%–12%. McIsaac 0–1: 7.6%–13.1%. Scoring is especially useful for identifying low testing yield.
Intermediate
Centor 2–3: 21%–38%. McIsaac 2–3: 20.8%–33.6%. Clinical context and diagnostic testing strategy matter.
High
Centor 4: about 57%. McIsaac 4–5: 50.7%–69.3%. High probability is still not confirmation.
These are estimated positive-test proportions, not the chance of a complication, the chance antibiotics will help a particular person, or the probability that every sore throat symptom is caused by GAS.
Clear viral features change the starting point
Cough, rhinorrhea, hoarseness, oral ulcers, and conjunctivitis can support a viral cause. CDC guidance says patients with clear viral symptoms generally do not need GAS testing. The original score includes only cough, so it can fail to capture the full viral pattern.
This calculator keeps a separate viral-pattern input. Selecting it does not change the historical arithmetic; instead, it changes the interpretation message. That preserves formula fidelity while preventing the total from obscuring information the formula never included.
Viral symptoms do not make every illness harmless. Influenza, COVID-19, mononucleosis, epiglottitis, deep neck infection, and other causes have different testing and care needs. A clinician evaluates the whole presentation.
Testing is a separate diagnostic step
Rapid antigen detection testing, nucleic acid amplification testing, and throat culture have different performance and local availability. CDC guidance recommends confirming symptomatic children age 3 and older who have a negative rapid antigen test with a throat culture; routine backup culture after a negative rapid test is generally not indicated for adults because acute rheumatic fever is rare.
Local protocols may use molecular testing differently. Specimen technique matters: swab the tonsillar pillars and posterior pharynx while avoiding the tongue and cheeks according to the test instructions. A poorly collected specimen can undermine an otherwise appropriate strategy.
A positive test can also reflect carriage in a person whose current symptoms are viral, especially in children. Test only when clinical evaluation makes the result meaningful.
Why the calculator does not prescribe antibiotics
Most sore throats are viral. Unnecessary antibiotics can cause rash, diarrhea, allergic reactions, Clostridioides difficile infection, drug interactions, and antimicrobial resistance. A score-based “automatic prescription” can treat people who test negative and miss alternative diagnoses.
When GAS is confirmed and treatment is indicated, the clinician considers allergies, previous reactions, age, weight, pregnancy, kidney function, drug interactions, local recommendations, and ability to complete therapy. The correct drug, dose, route, and duration are outside this score.
Do not share antibiotics or save doses for a future sore throat. Finishing or stopping a prescribed course should follow the treating professional’s directions, not symptom change or a recalculated Centor score.
Children under age 3 are outside this score
The 2025 IDSA scoring recommendation does not apply below age 3 because GAS may present with different features. This calculator blocks an age under 3 instead of adding a McIsaac point and pretending the validation applies.
Infants and toddlers with fever, feeding difficulty, breathing trouble, dehydration, unusual sleepiness, rash, or caregiver concern need age-appropriate pediatric evaluation. Exposure to a diagnosed household member and outbreak context can matter.
For all children, exact age, immunization status, medical history, weight, and examination guide care. A score never replaces pediatric assessment.
High-risk context can override a low score
IDSA notes that people with household GAS exposure, a history of rheumatic fever, or signs of complicated local or systemic GAS infection should be strongly considered for testing even if a clinical score is low. Immunocompromise or local outbreaks may also affect evaluation.
Possible peritonsillar or retropharyngeal abscess, scarlet fever, or toxic shock syndrome requires prompt assessment. A unilateral bulge, uvular deviation, trismus, neck swelling, severe pain, muffled voice, hypotension, or rapidly spreading rash is not a routine score-management scenario.
The separate high-risk switch changes the result message but not the points, because those contexts were not components of the Centor formula.
Limits of a four-feature rule
Centor was derived in 286 adults presenting to an emergency department in 1981. McIsaac expanded the framework with age. Pathogen prevalence, referral patterns, vaccines, testing technology, and healthcare access differ across time and setting.
Tenderness and tonsillar appearance are examiner-dependent. Fever may be measured or reported, and antipyretics can lower it. Cough may be mild or caused by another concurrent condition. These sources of variation are not represented in the integer total.
The score predicts likelihood of a positive GAS test, not severity. A person with zero points can still be very ill from another cause, and a person with four points may recover uneventfully after appropriate assessment.
A disciplined sore-throat pathway
Triage
Identify airway, swallowing, dehydration, abscess, systemic illness, and emergency warning signs.
Examine
Review viral features, exposure, age, temperature, nodes, tonsils, rash, and alternative diagnoses.
Score
Use Centor or McIsaac consistently to support a testing decision, not to declare a pathogen.
Test and treat
Follow current diagnostic and treatment guidance with age-appropriate follow-up.
Centor review checklist
- Confirm age 3 or older.
- Measure or document fever threshold.
- Ask whether cough is present.
- Examine anterior cervical nodes.
- Examine tonsils for swelling or exudate.
- Keep Centor and McIsaac separate.
- Apply the correct age modifier.
- Review clear viral features.
- Review household GAS exposure.
- Ask about prior rheumatic fever.
- Look for abscess and systemic warning signs.
- Use a validated testing strategy.
- Do not diagnose from score alone.
- Do not self-start antibiotics.
It does not determine urgent-care costs, insurance coverage, medical deductions, testing, diagnosis, or treatment.
Frequently asked questions
What are the four Centor criteria?
Fever above 38°C, absence of cough, tender swollen anterior cervical nodes, and tonsillar exudate or swelling each add one point.
How does McIsaac differ?
It uses the same four findings and adds an age modifier: +1 for ages 3–14, 0 for 15–44, and −1 at 45 or older.
Does a score of 4 prove strep throat?
No. The 2025 IDSA table places it in a high positive-test band, but many high-score patients still test negative.
Can the score tell me to take antibiotics?
No. It supports a testing decision. Diagnosis and treatment require current clinical guidance and patient-specific evaluation.
Can I use Centor for a 2-year-old?
No. The 2025 IDSA scoring recommendation does not apply under age 3 because presentation differs.
References
- 2025 IDSA guideline update on GAS pharyngitis risk assessment
- CDC adult outpatient antibiotic guidance
- CDC clinical guidance for group A streptococcal pharyngitis
- Centor et al., diagnosis of strep throat in adults
- McIsaac et al., validity of a sore-throat score in family practice
- Large-scale validation of Centor and McIsaac scores